These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

481 related items for PubMed ID: 2146178

  • 1. Reduced insulinotropic effects of glucagonlike peptide I-(7-36)-amide and gastric inhibitory polypeptide in isolated perfused diabetic rat pancreas.
    Suzuki S, Kawai K, Ohashi S, Mukai H, Murayama Y, Yamashita K.
    Diabetes; 1990 Nov; 39(11):1320-5. PubMed ID: 2146178
    [Abstract] [Full Text] [Related]

  • 2. Interaction of glucagon-like peptide-1(7-36) amide and gastric inhibitory polypeptide or cholecystokinin on insulin and glucagon secretion from the isolated perfused rat pancreas.
    Suzuki S, Kawai K, Ohashi S, Watanabe Y, Yamashita K.
    Metabolism; 1992 Apr; 41(4):359-63. PubMed ID: 1556941
    [Abstract] [Full Text] [Related]

  • 3. Comparison of GLP-1 (7-36amide) and GIP on release of somatostatin-like immunoreactivity and insulin from the isolated rat pancreas.
    Schmid R, Schusdziarra V, Aulehner R, Weigert N, Classen M.
    Z Gastroenterol; 1990 Jun; 28(6):280-4. PubMed ID: 2238756
    [Abstract] [Full Text] [Related]

  • 4. Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas.
    Fehmann HC, Göke R, Göke B, Bächle R, Wagner B, Arnold R.
    Biochim Biophys Acta; 1991 Feb 19; 1091(3):356-63. PubMed ID: 1705823
    [Abstract] [Full Text] [Related]

  • 5. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
    Nauck MA, Bartels E, Orskov C, Ebert R, Creutzfeldt W.
    J Clin Endocrinol Metab; 1993 Apr 19; 76(4):912-7. PubMed ID: 8473405
    [Abstract] [Full Text] [Related]

  • 6. Glucagonostatic and insulinotropic action of glucagonlike peptide I-(7-36)-amide.
    Komatsu R, Matsuyama T, Namba M, Watanabe N, Itoh H, Kono N, Tarui S.
    Diabetes; 1989 Jul 19; 38(7):902-5. PubMed ID: 2661287
    [Abstract] [Full Text] [Related]

  • 7. The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects.
    Elahi D, McAloon-Dyke M, Fukagawa NK, Meneilly GS, Sclater AL, Minaker KL, Habener JF, Andersen DK.
    Regul Pept; 1994 Apr 14; 51(1):63-74. PubMed ID: 8036284
    [Abstract] [Full Text] [Related]

  • 8. The enteroinsular axis in dipeptidyl peptidase IV-negative rats.
    Pederson RA, Kieffer TJ, Pauly R, Kofod H, Kwong J, McIntosh CH.
    Metabolism; 1996 Nov 14; 45(11):1335-41. PubMed ID: 8931636
    [Abstract] [Full Text] [Related]

  • 9. The incretin hormones GIP and GLP-1 in diabetic rats: effects on insulin secretion and small bowel motility.
    Edholm T, Cejvan K, Abdel-Halim SM, Efendic S, Schmidt PT, Hellström PM.
    Neurogastroenterol Motil; 2009 Mar 14; 21(3):313-21. PubMed ID: 19126188
    [Abstract] [Full Text] [Related]

  • 10. Effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-I-(7-36) on insulin secretion.
    Jia X, Brown JC, Ma P, Pederson RA, McIntosh CH.
    Am J Physiol; 1995 Apr 14; 268(4 Pt 1):E645-51. PubMed ID: 7733263
    [Abstract] [Full Text] [Related]

  • 11. Synergistic stimulatory effect of glucagon-like peptide-1 (7-36) amide and glucose-dependent insulin-releasing polypeptide on the endocrine rat pancreas.
    Fehmann HC, Göke B, Göke R, Trautmann ME, Arnold R.
    FEBS Lett; 1989 Jul 31; 252(1-2):109-12. PubMed ID: 2668027
    [Abstract] [Full Text] [Related]

  • 12. Altered glucose dependence of glucagon-like peptide I(7-36)-induced insulin secretion from the Zucker (fa/fa) rat pancreas.
    Jia X, Elliott R, Kwok YN, Pederson RA, McIntosh CH.
    Diabetes; 1995 May 31; 44(5):495-500. PubMed ID: 7729605
    [Abstract] [Full Text] [Related]

  • 13. Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.
    Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W.
    J Clin Invest; 1993 Jan 31; 91(1):301-7. PubMed ID: 8423228
    [Abstract] [Full Text] [Related]

  • 14. Effect of glucagon-like peptide-1 on insulin secretion.
    Shima K, Hirota M, Ohboshi C.
    Regul Pept; 1988 Aug 31; 22(3):245-52. PubMed ID: 3051138
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the effects of various C-terminal and N-terminal fragment peptides of glucagon-like peptide-1 on insulin and glucagon release from the isolated perfused rat pancreas.
    Suzuki S, Kawai K, Ohashi S, Mukai H, Yamashita K.
    Endocrinology; 1989 Dec 31; 125(6):3109-14. PubMed ID: 2684616
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the effects of glucagon-like peptide-1-(1-37) and -(7-37) and glucagon on islet hormone release from isolated perfused canine and rat pancreases.
    Kawai K, Suzuki S, Ohashi S, Mukai H, Ohmori H, Murayama Y, Yamashita K.
    Endocrinology; 1989 Apr 31; 124(4):1768-73. PubMed ID: 2564338
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the effect of GIP and GLP-1 (7-36amide) on insulin release from rat pancreatic islets.
    Siegel EG, Schulze A, Schmidt WE, Creutzfeldt W.
    Eur J Clin Invest; 1992 Mar 31; 22(3):154-7. PubMed ID: 1582439
    [Abstract] [Full Text] [Related]

  • 18. Physiological augmentation of amino acid-induced insulin secretion by GIP and GLP-I but not by CCK-8.
    Fieseler P, Bridenbaugh S, Nustede R, Martell J, Orskov C, Holst JJ, Nauck MA.
    Am J Physiol; 1995 May 31; 268(5 Pt 1):E949-55. PubMed ID: 7762650
    [Abstract] [Full Text] [Related]

  • 19. Effects of the novel (Pro3)GIP antagonist and exendin(9-39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin.
    Gault VA, O'Harte FP, Harriott P, Mooney MH, Green BD, Flatt PR.
    Diabetologia; 2003 Feb 31; 46(2):222-30. PubMed ID: 12627321
    [Abstract] [Full Text] [Related]

  • 20. Effects of sub-chronic exposure to naturally occurring N-terminally truncated metabolites of glucose-dependent insulinotrophic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), GIP(3-42) and GLP-1(9-36)amide, on insulin secretion and glucose homeostasis in ob/ob mice.
    Parker JC, Lavery KS, Irwin N, Green BD, Greer B, Harriott P, O'Harte FP, Gault VA, Flatt PR.
    J Endocrinol; 2006 Oct 31; 191(1):93-100. PubMed ID: 17065392
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.